Persistent cortical blindness after cyclosporine leukoencephalopathy

B Casanova, M Prieto, E Deya, C Gisbert, J Mir, J Berenguer, J J Vilchez – 30 December 2003 – Cyclosporine A (CyA)‐related cortical blindness is an uncommon complication of CyA therapy in patients undergoing liver transplantation. Characteristically, neurological symptoms associated with CyA treatment usually regress after cyclosporine withdrawal. We present a case of a liver transplant recipient in whom discontinuation of CyA therapy has resulted in only partial clinical improvement, and cortical blindness remains after 1 year of follow‐up.

Minimal criteria for placement of adults on the liver transplant waiting list: A report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases

M R Lucey, K A Brown, G T Everson, J J Fung, R Gish, E B Keeffe, N M Kneteman, J R Lake, P Martin, S V McDiarmid, J Rakela, M L Shiffman, S K So, R H Wiesner – 30 December 2003 – This report summarizes a recent meeting cosponsored by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases to formulate minimal criteria by which patients with severe liver disease will be placed on the waiting list for liver transplantation.

Hemodynamic effects of inhaled nitric oxide in four patients with severe liver disease and pulmonary hypertension

A M De Wolf, V Scott, R Bjerke, Y Kang, D Kramer, A Miro, J J Fung, F Dodson, T Gayowski, I R Marino, L Firestone – 30 December 2003 – Patients with moderate and severe pulmonary hypertension have a very high mortality rate when undergoing orthotopic liver transplantation. Because nitric oxide has been successful in reducing pulmonary artery pressures in certain patients with pulmonary hypertension, the efficacy of NO inhalation (40 and 80 ppm) in 4 patients with pulmonary hypertension associated with liver disease was determined.

Hepatitis G virus infection before and after liver transplantation. Liver Transplantation Database

J H Hoofnagle, M Lombardero, Y Wei, J Everhart, R Wiesner, R Zetterman, A J Yun, L Yang, J P Kim – 30 December 2003 – The hepatitis G virus is a newly discovered flavivirus that has been linked to acute and chronic hepatitis of unknown cause. We determined the prevalence of hepatitis G virus infection in 179 selected patients undergoing liver transplantation at three centers participating in the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Liver Transplantation Database.

Retransplantation for recurrent hepatitis C

P A Sheiner, L K Schluger, S Emre, S N Thung, J Y Lau, S R Guy, M E Schwartz, C M Miller – 30 December 2003 – Recurrence of hepatitis C virus (HCV) after orthotopic liver transplant (OLT) may be mild or may lead to progressive liver disease requiring retransplantation (re‐OLT). Results of re‐OLT for hepatitis C are not well known. We analyzed outcomes in 14 patients retransplanted for recurrent hepatitis C. All had evidence of recurrent hepatitis on multiple biopsies.

Subscribe to